These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17241101)

  • 1. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B; Wuestenfeld JC; Kindermann W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W; Meyer T
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial.
    Zügel M; Bizjak DA; Nussbaumer D; Winkert K; Takabayashi K; Kirsten J; Washington M; Treff G; Dreyhaupt J; Steeb L; Diel P; Parr MK; Steinacker JM; Persch H
    Trials; 2021 Dec; 22(1):903. PubMed ID: 34895300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbutaline: level the playing field for inhaled β
    Jacobson GA; Hostrup M
    Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of anti-asthmatic medication among Danish elite athletes].
    Lund TK; Pedersen L; Backer V
    Ugeskr Laeger; 2007 Dec; 169(50):4355-9. PubMed ID: 18211794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?
    Backer V; Lund T; Pedersen L
    Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
    Pluim BM; de Hon O; Staal JB; Limpens J; Kuipers H; Overbeek SE; Zwinderman AH; Scholten RJ
    Sports Med; 2011 Jan; 41(1):39-57. PubMed ID: 21142283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.
    van Baak MA; de Hon OM; Hartgens F; Kuipers H
    Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma medication in Finnish olympic athletes: no signs of inhaled beta2-agonist overuse.
    Alaranta A; Alaranta H; Palmu P; Alha P; Pietilä K; Heliövaara M; Helenius I
    Med Sci Sports Exerc; 2004 Jun; 36(6):919-24. PubMed ID: 15179158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
    Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V
    Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inhaled salbutamol in exercising non-asthmatic athletes.
    Goubault C; Perault MC; Leleu E; Bouquet S; Legros P; Vandel B; Denjean A
    Thorax; 2001 Sep; 56(9):675-9. PubMed ID: 11514686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
    McKenzie DC; Fitch KD
    Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs.
    Riiser A; Stensrud T; Stang J; Andersen LB
    Br J Sports Med; 2020 Nov; 54(22):1351-1359. PubMed ID: 32747344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma in elite athletes.
    Elers J; Pedersen L; Backer V
    Expert Rev Respir Med; 2011 Jun; 5(3):343-51. PubMed ID: 21702657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Asthma drugs and doping].
    Pillard F; Rolland Y; Rivière D
    Allerg Immunol (Paris); 1999 Nov; 31(9):317-9. PubMed ID: 10615514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
    Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
    Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.